Crossmark

Avoiding Catch-22: validating the PainDETECT in a population of patients with chronic pain

Crossref DOI link: https://doi.org/10.1186/s12883-018-1094-4

Published Online: 2018-06-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Timmerman, Hans https://orcid.org/0000-0002-6082-9043
Wolff, André P.

Bronkhorst, Ewald M.

Wilder-Smith, Oliver H. G.

Schenkels, Marcel J.

van Dasselaar, Nick T.

Huygen, Frank J. P. M.

Steegers, Monique A. H.

Vissers, Kris C. P.
Funding

Funding for this research was provided by:

DALI for PAIN
License Information

Text and Data Mining valid from 2018-06-29
More Information

Article History

Received: 24 April 2017

Accepted: 22 June 2018

First Online: 29 June 2018

Ethics approval and consent to participate

: This study was approved by the medical and ethical review board Committee on Research Involving Human Subjects region Arnhem-Nijmegen, Nijmegen, the Netherlands, Dossier number: 2008/348; NL 25343.091.08 and conducted in accordance with the declaration of Helsinki and the declaration of the World Medical Association. As required, written informed consent was obtained from patients prior to study participation. The protocol is registered in the Dutch National Trial Register: NTR 3030.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.